David A. Siegel Vor Biopharma Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 27,500 shares of VOR stock, worth $39,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,500
Previous 50,300
45.33%
Holding current value
$39,325
Previous $35,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VOR
# of Institutions
54Shares Held
54.9MCall Options Held
20.9KPut Options Held
2.1K-
Ra Capital Management, L.P. Boston, MA39.6MShares$56.7 Million0.71% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$9.1 Million3.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.78 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$1.54 Million0.41% of portfolio
-
Lynx1 Capital Management LP San Juan, PR637KShares$911,2210.27% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $54.4M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...